1. DiMasi, J., et al.: New drug development in the United States from 1963 to 1999. Clinical Pharmacology and Therapeutics 69(5), 186–196 (2001)
2. Ashburn, T., et al.: Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews 3(8), 28–55 (2004)
3. DiMasi, J., et al.: The price of innovation: new estimates of drug development costs. Journal of Health Economics 22(2), 151–185 (2003)
4. Anand, G.: How drug’s rebirth as treatment for cancer fueled price rises: once-demonized thalidomide boosts celgene’s sales; patients see costs soar. The Wall Street Journal 15(A1) (2004)
5. Noeske, T., Sasse, B., Strak, H., et al.: Predictiong compound selectivity by self-organizing maps: cross-activities of metabotropic glutamate receptor antagonists. Chem. Med. Chem. 1, 1066–1068 (2006)